Search

Tıbbi söylemde, bir kadın cinsel işlev bozukluğu olarak tanımlanan vajinismus, günümüzde genellikle DSM, ICD gibi tıbbi sınıflandırma sistemlerinin kriterlerine göre biyomedikal bakış açısıyla ele alınmaktadır. Bu çalışmanın amacı, vajinismusun tıbbileştirilmesini, Türkiye’de vajinismus yaşayan kadınların deneyimleri üzerinden, sosyal hizmet bağlamında değerlendirmektir. Çalışma kapsamında nitel araştırma yaklaşımı kullanılmış ve vajinismus deneyimine sahip 22 kadınla derinlemesine görüşmeler gerçekleştirilmiştir. Yapılan analiz sonucunda, katılımcıların vajinismusu fiziksel ya da psikolojik bir hastalık olarak görmedikleri, toplumsal cinsiyet eşitsizliği ve kadın cinselliğinin tabu olarak görülmesinden etkilenen bir durum olarak algıladıkları anlaşılmıştır. Kadınlığa dair sosyal inşalar, partnerlerin çeşitli tutumları ve sosyo-ekonomik faktörler vajinismus sürecini etkilemektedir. Toplumsal cinsiyet eşitsizliğinin giderilmesi, cinselliğin konuşulabilir hale getirilmesi, cinsellik eğitimleri, ücretsiz ve kolay ulaşılabilir destek alma mekanizmalarının sağlanması vajinismus bağlamında önemli görülmektedir. Vajinismusun, yalnızca heteronormativite odağında cinsel birleşme işlevinin sağlatılmasına indirgenen tıbbi çözümlerinin, kadınların gerçek sorunlarına çözüm olmada yeterli olmadığı düşünülmektedir. Geniş mesleki zenginliğiyle sosyal hizmetin, vajinismusta deneyimleri bütüncül ele alma, kadınları anlama, kadınlara kendi kaderlerini tayin etmede yardımcı olma ve takip etmek istedikleri yolda pek çok açıdan destek verme gibi uygulamalarla önemli bir mekanizma olduğu düşünülmektedir. Kadın cinsel sorunlarının ele alınması sürecine sosyal hizmet uzmanlarının dahil olması önemli görülmektedir., In medical discourse, vaginismus, which is defined as a female sexual dysfunction, is generally considered from a biomedical point of view according to the criteria of medical classification systems such as DSM and ICD. The aim of this study is to evaluate the medicalization of vaginismus in the context of social work through the experiences of women having vaginismus in Turkey. Within the scope of the study, a qualitative research approach is used and in-depth interviews were conducted with 22 women with vaginismus experience. As a result of the analysis, it is understood that the participants do not see vaginismus as a physical or psychological disease, but as a situation affected by gender inequality and female sexuality being seen as taboo. Social constructions of femininity, various attitudes of partners and socio-economic factors affect the vaginismus process. Elimination of gender inequality, making sexuality talkable, sexuality education, and providing free and easily accessible support mechanisms are considered important in the context of vaginismus. It is thought that the medical solutions of vaginismus, which are reduced to providing the sexual intercourse function only in the focus of heteronormativity, are not sufficient to solve the real problems of women. With its wide professional wealth, social work is thought to be an important mechanism with practices such as holistic approach to vaginismus experiences, understanding women, helping women determine their own destiny, and supporting them in many ways on the path they want to follow. It is considered important that social workers are involved in the process of addressing women's sexual problems.

Uvod: Motnje orgazma pri ženskah so druga najpogosteje opisana spolna težava žensk, za katero velja, da je vztrajna ali ponavljajoča se zamuda ali odsotnost orgazma po normalni fazi spolnega vzburjenja, ki povzroča izrazito stisko ali medosebne težave. Namen: Sistematično pregledati literaturo na temo vpliva endogenih in eksogenih dejavnikov, ki vplivajo na ženski orgazem. Metode dela: Uporabljena je bila deskriptivna metoda dela s sistematičnim pregledom literature s kvalitativnim pristopom. V raziskavo so bili vključeni izvirni in pregledni članki in raziskave v angleškem in slovenskem jeziku. Rezultati: Po pregledu literature smo ugotovili, da pojem orgazma nima natančne definicije. Najbolj poznana sta dva tipa orgazma, in sicer klitorisni in vaginalni orgazem. Klitorisni orgazem doživijo ženske ob stimulaciji klitorisa, vaginalni orgazem pa ob samem spolnem aktu. Orgazmične motnje so pri ženskah zelo pogosto pojav, o njem poroča 11–41 % žensk po celem svetu. Na samo pojavnost orgazma vplivajo endogeni in eksogeni dejavniki. Velik vpliv imajo možgani oziroma drugi nevrološki dejavniki, ki vplivajo nanje. Velik vpliv pa imajo tudi kultura, rasa in vzgoja. Razprava in zaključek: Motnje orgazma oziroma nepojavnost orgazma je med ženskami še vedno dokaj pogosta in kompleksa težava. Veliko vlogo pri ženskem orgazmu imajo možgani, predvsem v tem, kako se odzovejo na različne dražljaje po telesu. V diplomskem delu smo dejavnike razdelili v dve skupini, in sicer na endogene in eksogene dejavnike. Pod endogene dejavnike štejemo vpliv hormonov, menstruacijski ciklus, menopavzo, hormonsko kontracepcijo in različne bolezni. Med eksogene dejavnike pa smo prišteli vpliv kulture, rase, religije, izobrazbe in zaposlitev. Ker je ženski orgazem zelo kompleksna zadeva, so potrebne še nadaljnje raziskave. Introduction: Female orgasmic disorders are the second most common described sexual problems in women, which is considered to be the persistent or recurrent delay or absence of orgasm after normal phase of sexual arousal, causing sever distress or interpersonal problems. Purpose: Systematically review the literature on the influence of endogenous and exogenous factors on female orgasm was performed. Methods: A descriptive method of work was used with a systematic literature review with qualitative approach. Original and review articles and research in English and Slovenian were included in the research. Results: After the reviewing process, we found that the term orgasm does not have a precise definition. Two types of orgasm are best known, namely clitoral and vaginal orgasm. Clitoral orgasm is experienced by women during clitoral stimulation, and vaginal orgasm during sexual intercourse. Orgasmic disorders are very common in women, reported by 11-41% of women worldwide. The occurrence of orgasm itself is influenced by endogenous and exogenous factors. The brain has a great influence certain factors that affect brain function. Culture, race, and upbringing also have a great influence. Discussion and conclusion: Disorders of orgasm or the non-occurrence of orgasm is still a common and complex problem among women. The brain and its function play a big role in a woman's orgasm. how the brain responds to various stimuli throughout the body. In the diploma work, we divided the factors into two groups, namely endogenous and exogenous factors. Endogenous factors include the influence of hormones, the menstrual cycle, menopause, hormonal contraception, and various diseases. Exogenous factors included the influence of culture, race, religion, education, and employment. As the female orgasm is a very complex matter, further research is needed on this topic.

Female sexual dysfunctions represent a real widespread problem, usually faced from a psychological point of view; however, millions of women worldwide are impacted by pelvic floor dysfunction, personal shame and social taboos, however, continue to inhibit free conversation on the subject. Women’s quality of life is considerably improved by screening, diagnosing, and controlling urogenital and sexual issues. This review aims to provide a critical perspective of urogenital conditions and common disturbances in female sexual function associated with these issues. It also includes a discussion of postpartum pelvic dysfunction.

Objectives: Incidence and prevalence of patients in dialytic therapy increased considerably in recent years. The onset of new issues, once overshadowed, linked to a lower quality of life like sexual dysfunction became increasingly common. The first study in this area, dating back to the 1970s, shows the high prevalence of sexual dysfunction among patients in dialytic therapy of both sexes. Later studies proved an association of sexual dysfunction with psyche disorders, anxiety, depression and lack of self-confidence. The aim of this study is to describe the incidence of male and female sexual main dysfunctions, the latter not least in literature, in patients in hemodialytic therapy. With this aim two dialytic centers have been compared, one located in northern Italy and one in southern Italy, and the different prevalence has been compared to the general population. Methods: We conducted a prospective cross-sectional observational study in patients undergoing dialytic therapy in two hemodialysis centers, one located in Palermo and one in Lecco. Male sexual dysfunction was investigated by the International Index of Erectile Function-15 (IIEF15) questionnaire and the Premature Ejaculation Diagnotic Tool (PEDT) questionnaire, and the female dysfunction by Female Sexual Function Index (FSFI) questionnaire. Criteria for inclusion in our study were: age < 75 years and dialytic age > 3 months; exclusion criteria were: advanced cancer diseases, life expectancy < 6 months, previous urological manipulation, anti-androgenic therapy, sexual dysfunction unrelated to kidney disease, psychiatric disorders. Data were compared with mean-standard deviation (SD) and with the variance analysis (ANOVA). A value of p < 0.05 is considered significant. Discrete data were analyzed with contingency analysis. A chi2 < 0.05 was considered significant. Results: Data of 78 patients have been collected. Mean age and dialytic time were 54 ± 12 years and 42 ± 35 month; 33 patients were from Palermo and 24 from Lecco; 21 patients were excluded. Age and dialytic age of the two subgroups did not demonstrate statistically significant differences. Between the two centers there was a statistically significant difference (p < 0.005) in the distribution of basic nephropathy: an higher incidence of diabetic and obstructive nephropathy has been observed in the southern center compared to northern center, while glomerulonephritis and polycystic kidney disease had an higher incidence in the northern center compared to southern one. The main sexual dysfunctions in both sexes, erectile dysfunction (ED) and premature ejaculation (PE) in men and orgasm disorder and pelvic pain in women, have been investigated. ED was present in 70% of hemodialyzed patients, which is an higher incidence compared to the general population. The severity of ED between patients of the two groups was significantly different (chi2 < 0.001) with higher incidence of moderate/severe forms in northern Italy. The score, in addition to discrete data (severe, moderate, mild, absence), of ED was significantly different (p < 0.001) between patients of the two centers (22 ± 7 Palermo vs. 9 ± 8, Lecco). The PE was absent in 20 patients (54%), present in 12 patients (32%) and probable in 5 patients (14%) (scores of 7.6 ± 4.0 and 8.9 ± 6.8, respectively in Palermo and Lecco patients). For women, orgasmic dysfunction was severe in 10 patients (50%), mild in 4 patients (20%), very mild in 5 patients (25%), while it was normal in 1 patient (5%), with a statistically significant difference (p< 0.05) between Palermo and Lecco patients (3.0 ± 1.4 vs 1.2 ± 2.0). Sexual pain in women was severe in 11 patients (55%), moderate in 4 patients (20%) and mild in 5 patients (25%). Sexual pain was present in all patients (p < 0.05).Conclusions: Regardless of sex, sexual dysfunction is one of the most common side effect in patients with end stage renal disease in dialytic therapy. Our study confirms literature data. The growing number of the dialytic population with sexual disorders needs specialist support to improve quality of life of these patients.

The association between diabetes mellitus (and its micro- and macro-vascular complications) and erectile dysfunction is widely known and the presence of hypogonadism may further complicate sexual dysfunction and quality of life, given the association between hypogonadism and reduced libido, ejaculatory disorders, and depressive symptoms. However, the recent introduction of novel antidiabetic agents with a wide range of mechanism of action may have a significant impact both on male and female sexuality directly (by inducing side effects as urinary tract infections) and indirectly (improving metabolic status and reducing diabetes complications behind sexual dysfunctions). To date only few papers are reporting the sexual effects of these treatments and, often, these are not comparable in their results. Conversely, female sexual dysfunctions are somehow under-investigated. Data on prevalence is heterogeneous and specific pathogenic mechanisms, as well as the burden of psychological factors, are still heatedly debated. The aim of this narrative review is to summarize current knowledge and stressing out the need to diagnose male and female sexual dysfunctions also in light of the impact of treatments with novel antidiabetic agents. This would highlight the still unmet needs for sexual care in a diabetes care setting and could represent an incentive for future discussions, as well as a required theoretical starting point for studies on this subject.

OBJECTIVE: The Sexual Complaints Screener for Women (SCS-W) is a brief, practical and up-to-date scale which assesses sexual problems parallel with the current diagnostic manuals. The SCS-W consists of 10 questions which assess a variety of sexual dysfunctions and potential distress experienced at the time of and the last six months leading to the evaluation. This study aims to assess the validity and reliability parameters of the Turkish version of the SCS-W. METHODS: Cross-sectional study included 352 women between the ages of 18 and 25 who voluntarily completed the survey, 316 of which were included in the analysis. Data was collected through specific questionnaires including the Female Sexual Function Index, the Short Form Health Survey (SF-36), the Turkish translation of SCS-W, and a sociodemographic form. The Cronbach Alpha Test was used to calculate the internal consistency and the Pearson Correlation Test was used for total score correlations as well as to determine cross-validity. An explanatory factor analysis was applied to identify the validity of the scale. RESULTS: The average age of participants in the study was 21.17 ± 1.87. The Cronbach alpha internal consistency coefficient of the scale was 0.895, and the correlation coefficient for most of the items was found to be higher than 0.50. Correlation analysis between the SCS-W and the FSFI total score and subscales were statistically significant. CONCLUSION: The SCS-W has credible psychometric values for validity and reliability to screen and evaluate sexual complaints. To sum up, the SCS-W is a practical assessment tool with the considerable advantages of delivering cost-effective evaluation of female sexual problems in clinical settings, research, and daily practice.

Цель исследования: оценка сексуального здоровья женщин, мужчины которых страдают преждевременной эякуляцией. Материалы и методы. Проведено гинекологическое, сексологическое, психологическое обследование 28 женщин репродуктивного возраста, у мужчин которых выявлена преждевременная эякуляция. Результаты. Сексуальный дискомфорт и неудовлетворенность сексуальными отношениями отмечали 22 (78,6%) женщины. При этом снижение либидо установлено у 17 (60,7%) обследованных, первичную аноргазмию – у 2 (7,1%), вторичную аноргазмию – у 15 (53,6%), нарушение любрикации – у 22 (78,6%), диспареунию – у 25 (89,3%), сочетание сексуальных дисфункций – у 23 (82,1%). Сексуальные нарушения, выявленные у пациенток, формировались в течение 1–2 лет на фоне сексуальной дисгармонии пары (у мужчин установлена преждевременная эякуляция), сопровождаясь в 89,3% случаев спектром гинекологической патологии. Заключение. Проведение комплексной терапии с соблюдением принципов междисциплинарного подхода и гендерных соотношений является определяющим при восстановлении сексуальной гармонии пары. На клиническом примере продемонстрирована перспектива эффективного использования препарата дапоксетин (Priligy®, Прилиджи®) в терапии преждевременной эякуляции и восстановлении сексуального здоровья пары.

Introdução: A disfunção sexual feminina (DSF), apesar da alta prevalência (40-45%) no mundo, é frequentemente negligenciada na prática clínica. Existem diferentes testes para avaliação diagnóstica, porém, estes são formulados predominantemente para especialistas em sexualidade, são longos e muitos, não validados epidemiologicamente. Objetivos: O objetivo geral da presente tese é desenvolver e validar um instrumento rápido capaz de medir diferentes domínios da função sexual das mulheres, de forma prática e factível, para uma boa adesão por médicos não especialistas na área de sexualidade. Metodologia: Para a criação do teste, denominado U on Sex, foi utilizado um banco de dados de 378 mulheres atendidas em ambulatório de saúde sexual, em hospital público. Na identificação dos itens para melhor avaliar a função sexual feminina foi utilizada a metodologia de teoria de resposta ao item – TRI. Na validação ampliou-se a amostra inicial, incluindo 243 mulheres atendidas na atenção primária, e novamente sendo testadas pela TRI. A análise final foi realizada com amostra de 621 mulheres, contemplando mulheres com e sem queixa de disfunção sexual. O U on Sex, em sua validação concorrente, foi comparado ao FSFI, através do teste da correlação de Spearman. A validação do uso do instrumento por médicos não especialistas em sexualidade foi realizada comparando os resultados no re-teste do instrumento por especialistas em sexualidade. Resultados: Três itens - frequência, orgasmo e iniciativa – apresentaram poder discriminatório. O item “dor” foi pouco discriminatório. O U on Sex demostrou maior precisão na avaliação do nível de (dis)função sexual das mulheres que se encontram entre a média (zero) e um pouco menos de um desvio padrão acima da mesma. A correção em relação ao padrão ouro foi de 0,56 (valor p < 0,000. Na análise de acurácia o teste apresenta sensibilidade de 80% (IC 0,70-0,87) e especificidade de 53% (IC 0,45-0,61). Houve uma associação linear forte (0,8658) e significativa (valor p < 0,0001) na avaliação da aplicação do U on Sex por médicos não especialistas (NE) e especialistas em sexualidade (ES). Conclusão: O presente estudo demonstrou a capacidade do teste criado, o U on Sex, de identificar, com apenas três itens, o nível de função sexual feminina. Os itens frequência, orgasmo e iniciativa/interesse mostraram poder discriminatório. Recomenda-se compreender melhor o significado da dor na funcionalidade sexual feminina e o quanto os instrumentos utilizados refletem padrões de gênero. Priorizou-se a sensibilidade, pois como é um teste rápido de screening, para avaliar a funcionalidade sexual feminina, trata-se de abordagem inicial e breve, para sinalizar um possível diagnóstico de DSF. O instrumento U on Sex demonstrou ser um recurso com bom poder de identificação da função sexual e um rastreio inicial para possíveis disfunções, que devido os poucos itens facilita a abordagem do tema na prática clínica diária. Este teste rápido obteve forte índice de correlação quando comparada sua aplicação por médicos não especialistas com especialistas em sexualidade, demonstrando que o U on Sex pode ser um meio de acessar o diagnóstico de DSF, na atenção primária. Introduction Despite its high prevalence (40-45%) in the world, Female Sexual Dysfunction (FSD), is often neglected in clinical practice. There are different tests for diagnostic evaluation, however, these are predominantly formulated for specialists in sexuality, they are long and many of them are not epidemiologically validated. Objectives: The general objective of this thesis is to develop and validate a rapid instrument which can measure different domains of women's sexual function in a practical and feasible way, aiming at having good acceptance by non-specialists in the sexuality field. Methodology: For the creation of the test, called U on Sex, we used a database of 378 women seen at a sexual health outpatient clinic was used in a public hospital. In the identification of the items to better evaluate female sexual function, the methodology of item response theory - TRI was used. In validation, the initial sample was expanded, including 243 women treated in primary care, and again being tested by TRI. The final analysis was performed with a sample of 621 women, including women with and without complaints of sexual dysfunction. The U on Sex, in its concurrent validation, was compared to the FSFI, using the Spearman correlation test. The validation of the use of the instrument by physicians not specialists in sexuality was carried out comparing the results in the re-test of the instrument by specialists in sexuality. Results: Three items - frequency, orgasm and initiative - presented discriminatory power. The item "pain" was not very discriminatory. The U on Sex has shown greater accuracy in assessing the level of FSD among women who are between the average (zero) and slightly less than a standard deviation above it. The correction for the gold standard was 0.56 (p

Цель исследования: оценка сексуального здоровья женщин, мужчины которых страдают преждевременной эякуляцией. Материалы и методы. Проведено гинекологическое, сексологическое, психологическое обследование 28 женщин репродуктивного возраста, у мужчин которых выявлена преждевременная эякуляция. Результаты. Сексуальный дискомфорт и неудовлетворенность сексуальными отношениями отмечали 22 (78,6%) женщины. При этом снижение либидо установлено у 17 (60,7%) обследованных, первичную аноргазмию – у 2 (7,1%), вторичную аноргазмию – у 15 (53,6%), нарушение любрикации – у 22 (78,6%), диспареунию – у 25 (89,3%), сочетание сексуальных дисфункций – у 23 (82,1%). Сексуальные нарушения, выявленные у пациенток, формировались в течение 1–2 лет на фоне сексуальной дисгармонии пары (у мужчин установлена преждевременная эякуляция), сопровождаясь в 89,3% случаев спектром гинекологической патологии. Заключение. Проведение комплексной терапии с соблюдением принципов междисциплинарного подхода и гендерных соотношений является определяющим при восстановлении сексуальной гармонии пары. На клиническом примере продемонстрирована перспектива эффективного использования препарата дапоксетин (Priligy®, Прилиджи®) в терапии преждевременной эякуляции и восстановлении сексуального здоровья пары., Мета дослідження: оцінювання сексуального здоров’я жінок, чоловіки яких страждають на передчасну еякуляцію. Матеріали та методи. Проведено гінекологічне, сексологічне, психологічне обстеження 28 жінок репродуктивного віку, у чоловіків яких встановлено передчасну еякуляцію. Результати. Сексуальний дискомфорт та невдоволеність сексуальними стосунками зазначали 22 (78,6%) жінки. Зниження лібідо встановлено у 17 (60,7%) обстежених, первинну аноргазмію – у 2 (7,1%), вторинну аноргазмію – у 15 (53,6%), порушення любрикації – у 22 (78,6%), диспаревнію – у 25 (89,3%), поєднання сексуальних дисфункцій – у 23 (82,1%). Сексуальні розлади, виявлені у обстежених пацієнток, формувалися протягом 1–2 років на тлі сексуальних дисгармоній в парі (у чоловіка встановлено передчасну еякуляцію), супроводжувалися в 89,3% випадків спектром гінекологічної патології. Заключення. Проведення комплексної терапії із дотриманням принципів міждисциплінарного підходу та гендерних співвідношень є принциповим за умови відновлення сексуальної гармонії пари. На клінічному прикладі продемонстровано перспективу ефективного використання препарату дапоксетин у комплексній терапії передчасної еякуляції та відновлення сексуального здоров’я пари., The objective: to evaluate sexual health of women, whose men suffer from precocious ejaculation. Patients and methods. A gynaecological, sexological and psychological examination of 28 women of reproductive age, whose husbands were reported to have precocious ejaculation, was carried out. Results. Sexual discomfort and dissatisfaction of sexual relationships were reported by 22 (78,6%) women. Reduction of libido was established in 17 (60,7%) of the examined, primary anorgasmia – in 2 (7,1%), secondary anorgasmia – in 15 (53,6%), violation of lubrication – in 22 (78,6%), dyspareunia – in 25 (89,3%), and combination of sexual dysfunctions – in 23 (82,1%). Sexual disorders, revealed in the examined patients, were formed during 1–2 years at the background of sexual disharmonies in a couple (precocious ejaculation was established in husband’s body), accompanied in 89,3% of cases by the spectre of gynaecological pathology. Conclusions. Complex therapy in compliance with the principles of interdisciplinary approach and intergender correlations is a principle under the condition of restoration of sexual harmony in a couple. The clinical sample has demonstrated the trend of effective use of dapoxetine medicine in a complex therapy of precocious ejaculation and restoration of couple’s sexual health.

Female sexual dysfunctions are a highly prevalent and often-underestimated health problem and include disorders of sexual desire, arousal, orgasm and sexual pain, associated with self-distress. Pathophysiology of female sexual dysfunctions is complex and still poorly understood, although it has been related to several biological, medical and psychological factors. Amongst women, urogynecological disorders such as urinary incontinence, overactive bladder syndrome, bladder pain syndrome and pelvic organ prolapse, have been found to be associated with sexual dysfunctions, although the biological and psychological bases of these associations are poorly investigated. Data on sexual function impact of these conditions come from several cross-sectional or community-based, epidemiological studies based on self-administered validated psychometric tools. This review focuses on the most relevant available evidence on the impact of urogynecological disorders and related surgical treatments on female sexual function.

Questionnaires diagnosing sexual dysfunctions in women are important tools which can facilitate the diagnosis and therapy of individual female patients. The study is aimed at the adaptation of the Sexual Function Questionnaire, which was designed by Frances H. Quirk and associates for the American population, to Polish conditions (Quirk et al. in J Sex Med 4:469-77, 1). The study group consisted of 143 women aged 20-68 who were receiving gynaecological care and displayed various types of sexual dysfunction (e.g. female sexual arousal disorder, female orgasmic disorder, dyspareunia), or none of those. The good psychometric quality of the Sexual Function Questionnaire has been confirmed with the following results: convergent validity r(s)=0.62, p0.01, construct validity was estimated by Principal Component Analysis with the promax rotation method. The 7 factors together explained 80.7% of total variance, and a reliability of 0.97 for the whole test, with that for particular domains ranging from 0.62 to 0.96 (estimated with Cronbach's alpha). The obtained results are mostly consistent with results from studies conducted by the authors of the Questionnaire in the United States, and with the adaptation study carried out in Iran. There are, however, some differences in the assignment of questions to particular domains, as well as in the names of the domains.

The aim of our investigation is to explore a sexual life, experience and attitudes of women who are divided into for groups, according to their ability to reach orgasm during partnered sexual activities. We try to identify possible differences between these groups in diverse sexual areas. We do not formulate any hypothesis, our research has an exploratory character. We used data from 905 women, who participated in a nationwide research, that aims to investigate changes in Czech population sexual behavior. The research is in progress since 1993 and it repeats every five years. Our sample originates from a data collection in 2008. The data collection (using anonymous questionnaire) was conducted by a specialized agency DEMA a.s. The data were processed using SPSS 16.0. Our results are following: The orgastic ability decreases with age. Widows, pensioners, and Roman Catholics rarely experience orgasm. Highly orgasmic women are of higher education. These women engaged into partnered sexual activities (such as necking, petting, sexual intercourse) earlier than the less orgasmic women did. The highly orgasmic women more masturbate. They also reported a higher number of sexual partners during their life, and they engage into a casual sex and diverse sexual practices more often. Furthermore, the highly...